Recent publications and upcoming events

Read more
Event

SLTC 2020: where are we now?

Learn more
Click here
Event

Gilead at EASL 2020

The COVID-19 pandemic has fundamentally impacted all aspects of human life and put immense pressure on healthcare systems. For patients with chronic liver diseases, concerns have been raised about what the next few months will reveal in terms of increased morbidity and mortality resulting from delayed care and missed diagnoses. The impact of COVID-19 on achieving the WHO viral hepatitis elimination goals also cannot be forgotten. During this symposium, the expert faculty will explore how liver disease care has adapted in response to the pandemic and discuss the key learnings that should be taken forward to help re-imagine a ‘new normal’ of care beyond COVID-19.

Learn more
Click here
Publication

HCV elimination: when the incarcerated hold the key

Dr Stuart McPherson has a lofty ambition for his network: to be…

Learn more
Click here

LID/IHQ/18-12//1048(3) Date of preparation: September 2019